Patient Recruitment

Richmond Pharmacology is a leading clinical research organisation that helps sponsoring companies to enlist volunteers for trial medical therapies. Their ability to gather numerous volunteers in short notice is what makes them one of the leading companies in their field.

The company is one of Europe’s largest providers of Patient Recruitment and first in man studies and has been involved in patient recruitment in ther UK for almost ten years which has led them to become known as a Preferred Provider for patient recruitment

For years, Richmond Pharmacology has been recruiting from Japanese populations for years and has a dedicated Japanese in-house drafting department. Due to their innovative approach and marketing skills, the company receives 150-200 enquires per month from potential Japanese volunteers.

‘Our approach has been very successful to date as the marketing messages and advertising designs are constantly monitored to ensure they are tailored to the tastes of our Japanese student target population’, a company spokesperson stated, ‘To generate awareness and interest in our trials among the Japanese community, we deliver sustained and targeted marketing campaigns’.

Richmond Pharmacology’s most recent Japanese study included 18 Caucasian and 18 Japanese subjects. Two additional procedures were required for each subject to become part of the study which included a magnetic resonance imaging (MRI) scan and a baseline Positron Emission Tomography (PET) scan.

‘Trying to match the scan centre’s fixed schedule, possibly only 2-3 scans per week, to the availability of the Japanese subjects was a challenge. Due to the potential language barriers, we arranged for a member of our Japanese volunteer department team to‚Ķchaperone the subjects to the scan centre’, a company spokesperson stated.

These volunteer chaperones were beneficial for ensuring that all MRI appointments where a volunteer was available were met on time.

Teamwork was the main reason for the success of this particular project carried out by the Richmond Pharmacology management team, the Japanese workers in the Volunteer Recruitment Department and the team at the scan centre.

‘We kept in very close contact with the Director of Clinical Operations at the scan centre’, a company spokesperson said. ‘The sponsor told us that they did not know of any other CRO who would have been able to manage this study as successfully as we did’.

Communication was the key to success during this study. If a volunteer did not turn up for their appointment or the scan was unsuccessful, the scan team would phone Richmond Pharmacology immediately. As the team at Richmond Pharmacology is flexible, they were able to adapt to these changes and allocate appointments for 36 subjects from initial screenings of MRIs to baseline PETs and the treatment PET scan.

Due to the excellent study management, was given follow up business to perform a similar study with the exclusion of poor and intermediate metabolisers. Their ability to continually rise to the challenge has led to their reputation as CRO leaders that produce a high standard of professionalism within allocated budgets and time frames.